Abstract
A retrospective study was made of 36 patients with primary gastrointestinal (GI) non-Hodgkin lymphoma (NHL), of which 16 occurred in stomach, 14 in small intestine, 3 in ileocecal region and 3 in large intestine. The mean age was 57 years. According to the 'Working Formulation' large cell lymphomas were most common. All patients were surgically explored, 27 undergoing resection and 9 laparotomy with biopsy. Radiotherapy was given to 14 patients and 27 received chemotherapy. Patients with stomach as the primary site had a slightly better outlook than patients with intestinal tumors. In patients with stage I and II disease the group which had been resected and received both radiation treatment and chemotherapy had the best prognosis with a 3-year survival of 76%. The material also indicates that radiotherapy is of value for GI-NHL in stage I or II.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
